GenHealth.ai Raises $16.5M for Medical Back-Office AI

GenHealth.ai, a healthcare AI company building agents that handle administrative work directly inside provider offices, secured $16.5 million in Series A funding, bringing the company's total funding to $30 million, according to Fierce Healthcare's reporting on the round. Flare Capital Partners led the round, with participation from existing investors Craft Ventures and Obvious Ventures, alongside new investors Eniac Ventures, InHealth Ventures, Epsilon Health Investors, and ARTIS.

Founded in 2023, GenHealth's agents complete revenue cycle workflows end-to-end across electronic health records, payer portals, and other systems, handling intake, eligibility verification, prior authorizations, billing, and denials, according to Fierce Healthcare's reporting. Rather than simply generating suggestions for staff to act on, the agents work directly inside the systems providers already use, completing the actual administrative labor rather than layering another tool on top of existing workflows.

Flare Capital Partners partner Vic Lanio was direct about why this specific approach drove the firm's decision to lead the round. "Provider organizations do not need another system of record. They need the work done," Lanio said in a statement. "GenHealth is not just agentified SaaS. They have AI agents working alongside humans, in the providers' systems, completing the work. That's why we led this round." That distinction, genuine task completion versus another dashboard requiring human action, reflects a broader pattern we've tracked closely across enterprise AI this year, where investors increasingly favor companies whose agents do real work rather than simply surface information for humans to act on.

GenHealth.ai at a Glance

GenHealth CEO Ricky Sahu identified a specific, technical reason he believes healthcare administrative automation has historically underdelivered. "The problem with automating healthcare administration isn't just the AI, it's that the AI is disconnected from the workflows and systems providers already use, like EHRs, payer portals, fax and bank accounts," Sahu said in a statement. "At GenHealth, we've built these connections directly and created the infrastructure for AI agents to execute complex workflows reliably, with additional context from our own model trained on data from 140 million patients. The result is patients getting care faster and providers getting paid over 30% more. That outcome is virtually unheard of in RCM," referring to revenue cycle management, the broader industry term for the billing and payment process this technology targets.

GenHealth's growth metrics support the investor enthusiasm with concrete numbers. The company's revenue has quadrupled in the past six months, with its agents on track to take more than 75 million actions inside customer systems, according to Fierce Healthcare's reporting, a genuinely substantial operational scale for a company still in its Series A stage.

GenHealth's raise lands amid intense investor activity across healthcare AI agents specifically. Fierce Healthcare's own fundraising tracker shows a wave of comparable recent deals, including Assort Health's $120 million Series C for voice AI agents reaching unicorn status, EliseAI's $250 million Series E, and Tennr's $101 million raise for automating document-heavy administrative workflows, connecting directly to the broader enterprise AI agent investment pattern we've tracked closely, including Owner's $240 million raise applying a similar genuine-labor-substitution model to restaurants and small businesses.

GenHealth's raise is worth understanding for any healthcare provider organization evaluating administrative automation tools, since the company's specific emphasis on deep system integration, connecting directly to EHRs, payer portals, and even fax and bank accounts, addresses a genuine, well-documented failure point that has limited prior generations of healthcare automation software.

For businesses in healthcare technology or adjacent administrative-heavy industries, GenHealth's disclosed metrics, quadrupled revenue and a claimed 30% increase in provider payments, offer a genuinely useful benchmark for evaluating whether competing AI agent vendors can back up similar claims with comparable, verifiable performance data.

What does GenHealth.ai's platform actually do?
GenHealth builds AI agents that complete healthcare revenue cycle workflows end-to-end, handling patient intake, insurance eligibility checks, prior authorizations, billing, and denial management directly inside the electronic health records and payer portal systems providers already use.

How much funding has GenHealth.ai raised?
GenHealth.ai raised $16.5 million in Series A funding led by Flare Capital Partners, bringing its total funding to $30 million since founding in 2023.

How is GenHealth.ai's growth actually performing?
The company's revenue has quadrupled over the past six months, with its AI agents on track to complete more than 75 million actions inside customer systems, and the company claims providers using its platform get paid more than 30% faster.

GenHealth.ai raised $16.5 million in Series A funding led by Flare Capital Partners to scale its AI agents that complete medical billing and administrative work end-to-end inside provider systems, bringing total funding to $30 million. The company's revenue has quadrupled over the past six months, with its agents on track to take more than 75 million actions inside customer systems, drawing on a proprietary model trained on data from 140 million patients. The raise adds to a genuinely crowded wave of healthcare AI agent investment this year, with investors increasingly favoring companies whose agents complete real administrative work directly rather than simply surfacing information for staff to act on.